(CLDX) |
| 0 (0%) 10-10 18:21 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 32.68 |
| Resistance 1: | 27.98 |
| Pivot price: | 25.99 |
| Support 1: | 24.56 |
| Support 2: | 22.44 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -231400000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | -53.233 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -8.00 |
| Return on Assets (ttm) | 747.5 |
| Return on Equity (ttm) | -19.1 |
Company news
Fri, 10 Oct 2025
What analysts say about CLDX stock - Stock Correlation Metrics & Exceptional Profit Growth Tips - earlytimes.in
Fri, 10 Oct 2025
What machine learning models say about CLDX - Quarterly Trade Report & High Accuracy Swing Trade Signals - newser.com
Thu, 09 Oct 2025
Celldex Therapeutics (NASDAQ:CLDX) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Wed, 08 Oct 2025
Celldex Bets Big On Its Allergy Pipeline Breakthroughs - Finimize
Tue, 07 Oct 2025
Celldex Therapeutics (NASDAQ:CLDX) Share Price Crosses Above 200 Day Moving Average - Here's Why - MarketBeat
Mon, 06 Oct 2025
Celldex Therapeutics Getting Closer To Key Technical Benchmark - Investor's Business Daily
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
